The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
New research points to a possible link between autism spectrum disorder (ASD) and the gut microbiota as many autistic children have co-occurring gastrointestinal problems. This review focuses on specific alterations of gut microbiota mostly observed in autistic patients. Particularly, the mechanisms through which such alterations may trigger the production of the bacterial metabolites, or leaky gut in autistic people are described. Various altered metabolite levels were observed in the blood and urine of autistic children, many of which were of bacterial origin such as short chain fatty acids (SCFAs), indoles and lipopolysaccharides (LPS). A less integrative gut-blood-barrier is abundant in autistic individuals. This explains the leakage of bacterial metabolites into the patients, triggering new body responses or an altered metabolism. Some other co-occurring symptoms such as mitochondrial dysfunction, oxidative stress in cells, altered tight junctions in the blood-brain barrier and structural changes in the cortex, hippocampus, amygdala and cerebellum were also detected. Moreover, this paper suggests that ASD is associated with an unbalanced gut microbiota (dysbiosis). Although the cause-effect relationship between ASD and gut microbiota is not yet well established, the consumption of specific probiotics may represent a side-effect free tool to re-establish gut homeostasis and promote gut health. The diagnostic and therapeutic value of bacterial-derived compounds as new possible biomarkers, associated with perturbation in the phenylalanine metabolism, as well as potential therapeutic strategies will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Methodical approach of this systematic review due to PRISMA criteria [39].](https://figures.cochat.ai/paper-figures/995f3e7c1bdb4e7fa5d481ab1b14c477/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-1.jpg)


![Figure 4 Process of Clostridium tetani infection in the gut. Occurrence of the bacterium Clostridium tetani in the GI tract of autistic population could lead to altered behaviour. [43].](https://figures.cochat.ai/paper-figures/43898fd3bd604a37b876bb8b1235dffb/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-4.jpg)
![Figure 5 Metabolic pathways of tryptophan. The purple pathways show human metabolism of tryptophan and the orange pathways are observed in bacterial degradation. Green surrounded boxes show elevated metabolites and red surrounded boxes show decreased metabolites in the autistic metabolome [101].](https://figures.cochat.ai/paper-figures/cbe7bd9ad387486b9f15801bc57a30b3/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased BBB permeability has been associated with heightened microglial activity and a reduction in astrocyte numbers and functionality [52,76].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies has shown a significant increase in the prevalence of Clostridium bacteria in ASD patients compared to the general population [8,50,52,96,97,98,99,100,101,102,103,104,105,106,107,108,109].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A notable decrease in the prevalence of bacteria from the Veillonellaceae and Streptococcaceae families was observed in patients with ASD.”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was also observed that the abundance of the genus Faecalibacterium, particularly the Faecalibacterium prausnitzii species, should be lower in healthy individuals compared to patients diagnosed with ASD [52,89,101,107,109,113].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, the presence of Staphylococcus, Coprococcus, Lactococcus, and Flavonifractor may be detected in lower quantities [8,52,107,111,114,115].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 2×
“ethodical approach of this systematic review due to PRISMA criteria [39].”
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283 · cited 8×
“Sci. 2019, 20, 2115 19 of 28 Lactobacillus rhamnosus, Bifidobacterium infantis, Bifidobacterium longus, Lactobacillus helveticus, Lactobacillus reuteri and Lactobacillus paracasei Improvement of GI problems Humans [106] Lactobacillus reuteri - Reversing inflammation caused through lipopolysaccharides - Stimulating the…”
BackgroundInfluentialInteractions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · cited 1×
“The microbial composition varies through age, diet, diseases, geography [37,68] and shared environment [34].”
BackgroundGut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391 · cited 13×
“Especially, faecal microbiota transfers significantly ameliorated ASD behavioural symptoms and GI problems in autistic children [79].”
BackgroundMethodInfluentialHow informative is the mouse for human gut microbiota research?
Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017400 · Cited by 1,334
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Iglesias-Vázquez, L., Van Ginkel Riba, G., Arija, V., & Canals, J. (2020) · Nutrients · doi:10.3390/nu12030792 · Cited by 352
“Some of these are involved in the metabolism of sulfur and methylation, which contribute to the reduction of oxidative stress, cell detoxification, and excretion of heavy metals [45].”
BackgroundInfluentialThe Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
An, L., Wirth, U., Koch, D., Schirren, M., Drefs, M., Koliogiannis, D., Nieß, H., Andrassy, J., Guba, M., Bazhin, A. V., et al. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05188-7 · Cited by 284
Wang, Y., Li, N., Yang, J.-J., Zhao, D.-M., Chen, B., Zhang, G.-Q., Chen, S., Cao, R.-F., Yu, H., Zhao, C.-Y., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104784 · Cited by 324
The promotion mechanism of prebiotics for probiotics: A review
You, S., Ma, Y., Yan, B., Pei, W., Wu, Q., Ding, C., & Huang, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1000517 · Cited by 295
Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions
Ristori, M. V., Quagliariello, A., Reddel, S., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L. (2019) · Nutrients · doi:10.3390/nu11112812 · Cited by 214
“Significant deviations in the bacterial metabolites present in faeces and urine of children with ASD were seen [173].”
BackgroundThe Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease
Tran, S. M.-S., & Mohajeri, M. H. (2021) · Nutrients · doi:10.3390/nu13030732 · Cited by 210
“The previously mentioned metabolite and uremic toxin p-cresol (or its hepatically sulfonated form p-cresol sulphate) in ASD [142] is generated through intestinal bacterial Tyr metabolization [134], with especially strong producers within Coriobacteriaceae and Clostridium clusters XI and XIVa [137].”
BackgroundSelf-citationDisorders of the enteric nervous system — a holistic view
Niesler, B., Kuerten, S., Demir, I. E., & Schäfer, K.-H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00385-2 · Cited by 196
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation
Taniya, M. A., Chung, H.-J., Al Mamun, A., Alam, S., Aziz, M. A., Emon, N. U., Islam, M. M., Hong, S.-T. S., Podder, B. R., Ara Mimi, A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.915701 · Cited by 207
You’ve got male: Sex and the microbiota-gut-brain axis across the lifespan
Jaggar, M., Rea, K., Spichak, S., Dinan, T. G., & Cryan, J. F. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100815 · Cited by 200
Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders
Karakan, T., Özkul, C., Akkol, E. K., Bilici, S., Sobarzo‐Sánchez, E., & Capasso, R. (2021) · Nutrients · doi:10.3390/nu13020389 · Cited by 175
“As a neurodevelopmental condition, autism spectrum disorder has also been linked to gut microbiota-brain axis dysfunction [90].”
BackgroundMhanna, A., Martini, N., Hmaydoosh, G., Hamwi, G., Jarjanazi, M., Zaifah, G., Kazzazo, R., Mohamad, A. H., & Alshehabi, Z. (2024) · Medicine · doi:10.1097/md.0000000000037114 · Cited by 180
“[1,2] A balanced microbiota population is crucial for homeostasis, [3] Therefore, the abnormal composition of human microbiota may lead to several illnesses like immune system issues, infections, and neuropsychiatric disorders.”
BackgroundGut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice
Tengeler, A. C., Dam, S. A., Wiesmann, M., Naaijen, J., van Bodegom, M., Belzer, C., Dederen, P. J., Verweij, V., Franke, B., Kozicz, T., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00816-x · Cited by 146
“Previous research has demonstrated changes in the gut microbiota of children with ASD compared to healthy controls, including a higher Firmicutes/Bacteroidetes ratio and a higher relative abundance of Clostridia species [30, 32], whereas MDD has been associated with an increased microbiota alpha diversity [33].”
Plaza-Díaz, J., Solís-Urra, P., Rodríguez-Rodríguez, F., Olivares-Arancibia, J., Navarro-Oliveros, M., Abadía-Molina, F., & Álvarez-Mercado, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218351 · Cited by 145
Eicher, T. P., & Mohajeri, M. H. (2022) · Nutrients · doi:10.3390/nu14132661 · Cited by 142
“031 46 (♀-; ♂-) ASD: 33 Control: 13 ASD: 2–9 Control: 2–9 [44,45],[55]”
BackgroundInfluentialSelf-citationGut microbiota changes in children with autism spectrum disorder: a systematic review
Ho, L. K. H., Tong, V. J. W., Syn, N., Nagarajan, N., Tham, E. H., Tay, S. K., Shorey, S., Tambyah, P. A., & Law, E. C. N. (2020) · Gut Pathogens · doi:10.1186/s13099-020-0346-1 · Cited by 149
Feng, S., Zeng, Y., Cai, Z., Wu, J., Chan, L. L., Zhu, J., & Zhou, J. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143558 · Cited by 147
Knuesel, T., & Mohajeri, M. H. (2021) · Nutrients · doi:10.3390/nu14010037 · Cited by 109
“A disturbed intestinal microbiota, often associated with reduced diversity, was found in a variety of diseases, including hypertension [13], obesity [14], gastrointestinal disorders (such as inflammatory bowel disease (IBD) [15,16], and IBS [17]), brain disorders (such as Alzheimer’s disease [18], Parkinson’s disease…”
BackgroundSelf-citationBacterial Peptidoglycans from Microbiota in Neurodevelopment and Behavior
Gonzalez-Santana, A., & Diaz Heijtz, R. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.05.003 · Cited by 118
“These associations of ASD with increased prevalence of GI issues and reports of altered gut bacterial composition in this population motivate further explorations into the precise molecular mechanisms mediating the crosstalk between the gut microbiota and the developing brain [26, 30].”
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Zhuang, H., Liang, Z., Ma, G., Qureshi, A., Ran, X., Feng, C., Liu, X., Yan, X., & Shen, L. (2024) · MedComm · doi:10.1002/mco2.497 · Cited by 138
“128,180 MIA induces an immune response in pregnant women, leading to further inflammation and oxidative stress, as well as mitochondrial dysfunction in the placenta and fetal brain.”
The Role of Microbiome in Brain Development and Neurodegenerative Diseases
Nandwana, V., Nandwana, N. K., Das, Y., Saito, M., Panda, T., Das, S., Almaguel, F. A., Hosmane, N. S., & Das, B. C. (2022) · Molecules · doi:10.3390/molecules27113402 · Cited by 140
“, intestinal permeability produced by a loss in barrierforming tight junctions might be a possible biomarker in ASD pathophysiology [74].”
BackgroundGut microbiota and Autism Spectrum Disorder: From pathogenesis to potential therapeutic perspectives
Mehra, A., Arora, G., Sahni, G., Kaur, M., Singh, H. B., Singh, B., & Kaur, S. (2022) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2022.03.001 · Cited by 127
Shobeiri, P., Kalantari, A., Teixeira, A. L., & Rezaei, N. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00422-6 · Cited by 125
The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD
Bull-Larsen, S., & Mohajeri, M. H. (2019) · Nutrients · doi:10.3390/nu11112805 · Cited by 106
“Research highlights this risk, as gut dysbiosis in child or adulthood has not only been associated with various diseases, such as irritable bowel syndrome [6] or obesity [7], but also with psychiatric disorders as, for example, depression [8], Parkinson′s disease (PD) [9], schizophrenia [10], autism spectrum disorder…”
BackgroundSelf-citationBeneficial effects of butyrate on brain functions: A view of epigenetic
Alpino, G. D. C. Á., Pereira-Sol, G. A., Dias, M. D. M. E., Aguiar, A. S. D., & Peluzio, M. D. C. G. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2137776 · Cited by 110
“Evidences from animals and humans suggest that perturbation of gut microbiota and its metabolites are part of the genesis and development of ASD (Adams et al. 2011; Srikantha and Mohajeri 2019; Fattorusso et al. 2019).”
BackgroundComo, D. H., Duker, L. I. S., Polido, J. C., & Cermak, S. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010135 · Cited by 137
Microbiota in Autism Spectrum Disorder: A Systematic Review
Lewandowska, Z., Figlerowicz, M., & Mazur‐Melewska, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316660 · Cited by 112
“In MAs and SRs, the abundance was higher in ASD patients in Pseudomonadota on the phylum level [15,23,27] and on the genus level: Parabacteroides [15,23,27], Clostridium [14,15,23,27], Dorea [23,27], Ruminococcus [18,23,27], Faecalibacterium [15,19,23], and Sutterella [14,23,27].”
BackgroundEltokhi, A., Janmaat, I. E., Genedi, M., Haarman, B. C. M., & Sommer, I. E. C. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24616 · Cited by 98
“…2017; Tomova et al., 2015; Wang, Zhou, et al., 2019; Zhai et al., 2019; Zhang, Ma, Zhang, He, & Wang, 2018; for reviews, see Madore et al., 2016; Srikantha & Mohajeri, 2019; Vuong & Hsiao, 2017), ADHD (Aarts et al., 2017; Cenit, Nuevo, CodonerFranch, Dinan, & Sanz, 2017; Ming et al., 2018;…”
Niu, M., Li, Q., Zhang, J., Wen, F., Dang, W., Duan, G., Li, H., Ruan, W., Yang, P., Guan, C., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01084 · Cited by 92
Neuroinflammation: A Signature or a Cause of Epilepsy?
Pracucci, E., Pillai, V., Lamers, D., Parra, R., & Landi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136981 · Cited by 107
Dargenio, V. N., Dargenio, C., Castellaneta, S., De Giacomo, A., Laguardia, M., Schettini, F., Francavilla, R., & Cristofori, F. (2023) · Nutrients · doi:10.3390/nu15071620 · Cited by 98
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota
Settanni, C. R., Bibbò, S., Ianiro, G., Rinninella, E., Cintoni, M., Mele, M. C., Cammarota, G., & Gasbarrini, A. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1869938 · Cited by 98
“parallel around the age of two to 3 years, which is also a critical period for the onset of ASD[17].”
BackgroundTartaglione, A. M., Villani, A., Ajmone-Cat, M. A., Minghetti, L., Ricceri, L., Pazienza, V., De Simone, R., & Calamandrei, G. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02149-9 · Cited by 91
In Pursuit of Healthy Aging: Effects of Nutrition on Brain Function
Melzer, T. M., Manosso, L. M., Yau, S.-Y., Gil-Mohapel, J., & Brocardo, P. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095026 · Cited by 83
The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?
d’Angelo, M., Cimini, A., Castelli, V., Quintiliani, M., Benedetti, E., & Cifone, M. G. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295270 · Cited by 98
“, 2019; Grasset and Burcelin, 2019), psychiatric disorders, including autism, anxiety, and neurodegenerative disorders (Breit et al., 2018; Srikantha and Mohajeri, 2019).”
BackgroundRole of gastrointestinal health in managing children with autism spectrum disorder
Al‐Beltagi, M., Saeed, N. K., Bediwy, A. S., Elbeltagi, R. M., & Alhawamdeh, R. (2023) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v12.i4.171 · Cited by 105
Yang, J., Fu, X. B., Liao, X., & Li, Y. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113471 · Cited by 94
The Promising Role of Probiotics in Managing the Altered Gut in Autism Spectrum Disorders
Abdellatif, B., McVeigh, C., Bendriss, G., & Chaari, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114159 · Cited by 84
Keller, A., Rimestad, M. L., Rohde, J. F., Petersen, B. H., Korfitsen, C. B., Tarp, S., Lauritsen, M. B., & Händel, M. N. (2021) · Nutrients · doi:10.3390/nu13020470 · Cited by 102
“Also, by-products from the microbiota have been suggested to influence the synthesis of neuropeptides like serotonin, and peptides from gluten and casein have been hypothesized to increase the activity of the opioid system [10].”
BackgroundBoonchooduang, N., Louthrenoo, O., Chattipakorn, N., & Chattipakorn, S. C. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02383-1 · Cited by 87
AL-Ayadhi, L. Y., Zayed, N., Bhat, R. S., Moubayed, N., Al-Muammar, M. N., & El-Ansary, A. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00448-y · Cited by 81
“As mentioned earlier, this bacterium is usually involved in the maintenance of TJs in the intestinal epithelial barrier [69], and its diminution has been associated directly with chronic constipation in typically normal children [69].”
BackgroundHe, J., Gong, X., Hu, B., Lin, L., Lin, X., Gong, W., Zhang, B., Cao, M., Xu, Y., Xia, R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-46566-2 · Cited by 88
Oral microbiota and autism spectrum disorder (ASD)
Olsen, I., & Hicks, S. D. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2019.1702806 · Cited by 80
“Co-occurring diseases in ASD (from ref [29]).”
BackgroundInfluentialThe Gut Microbiota and Oxidative Stress in Autism Spectrum Disorders (ASD)
Hu, T., Dong, Y., He, C., Zhao, M., & He, Q. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8396708 · Cited by 82
Singh, J., Vanlallawmzuali, Singh, A. K., Biswal, S., Zomuansangi, R., Lalbiaktluangi, C., Singh, B. P., Singh, P. K., Vellingiri, B., Iyer, M., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104068 · Cited by 76
Gut microbiome and attention deficit/hyperactivity disorder: a systematic review
Gkougka, D., Mitropoulos, K., Tzanakaki, G., Panagouli, E., Psaltopoulou, T., Thomaidis, L., Tsolia, M., Sergentanis, T. N., & Tsitsika, A. (2022) · Pediatric Research · doi:10.1038/s41390-022-02027-6 · Cited by 69
The Role of Gut Microbiota in Gastrointestinal Symptoms of Children with ASD
Martínez-González, A. E., & Andreo-Martínez, P. (2019) · Medicina · doi:10.3390/medicina55080408 · Cited by 67
“In this sense, people with ASD with GI symptoms exhibit more anxiety problems and other somatic complaints, together with less social interaction than ASD people without GI symptoms [8].”
BackgroundInfluentialLasheras, I., Seral, P., Latorre, E., Barroso, E., Gracia‐García, P., & Santabárbara, J. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.101874 · Cited by 72
Duque, A. L. R. F., Demarqui, F. M., Santoni, M. M., Zanelli, C. F., Adorno, M. Â. T., Milenković, D., Mesa, V., & Sivieri, K. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110657 · Cited by 70
Feng, P., Zhao, S., Zhang, Y., & Li, E. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1123462 · Cited by 62
Li, F., Ke, H., Wang, S., Mao, W., Fu, C., Chen, X. X., Fu, Q., Qin, X., Huang, Y., Li, B., et al. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00993-9 · Cited by 68
Song, W., Zhang, M., Teng, L., Wang, Y., & Zhu, L. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001510 · Cited by 64
Mast Cells, Stress, Fear and Autism Spectrum Disorder
Theoharides, T. C., Kavalioti, M., & Tsilioni, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153611 · Cited by 67
“Environmental triggers have been implicated in ASD [17,109–112], including air pollutants [113,114], and a variety of pathogens [103].”
BackgroundLaue, H. E., Korrick, S., Baker, E., Karagas, M. R., & Madan, J. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-72386-9 · Cited by 68
Gut Microbiota and Neuroplasticity
Murciano-Brea, J., García-Montes, M. E., Geuna, S., & Herrera‐Rincon, C. (2021) · Cells · doi:10.3390/cells10082084 · Cited by 68
Kong, Q., Chen, Q., Mao, X., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14081615 · Cited by 59
He, X., Tu, Y., Song, Y., Yang, G., & You, M. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111902 · Cited by 62
Önal, S., Sachadyn‐Król, M., & Kostecka, M. (2023) · Nutrients · doi:10.3390/nu15234852 · Cited by 70
“…reported that Candida spp. may increase serotonin production in the intestine (5-hydroxytryptamine, 5-HT) and reduce serotonin synthesis in the brain (due to the consumption tryptophan, a precursor of serotonin), which can lead to hyperserotonemia and behavioral outcomes in ASD children [96].”
BackgroundPietrucci, D., Teofani, A., Milanesi, M., Fosso, B., Putignani, L., Messina, F., Pesole, G., Desideri, A., & Chillemi, G. (2022) · Biomedicines · doi:10.3390/biomedicines10082028 · Cited by 63
“Notably, lower levels of the Prevotella genus have been correlated with vitamin B1 deficiency [78].”
BackgroundFeeding and Swallowing Issues in Autism Spectrum Disorders
Adams, S. N. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s332523 · Cited by 62
“The purpose of this review is to discuss the nature and complexities of feeding difficulties in children with ASD.”
BackgroundInfluentialYe, F., Gao, X., Wang, Z., Cao, S., Liang, G., He, D., Lv, Z., Wang, L., Xu, P., & Zhang, Q. (2021) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.03.003 · Cited by 61
“A number of studies have shown that some species of Bifidobacterium produce GABA (gamma aminobutyric acid) [35], the concentrations of which have been found to be low in ASD children.”
ResultGuidetti, C., Salvini, E., Viri, M., Deidda, F., Amoruso, A., Visciglia, A., Drago, L., Calgaro, M., Vitulo, N., Pane, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185263 · Cited by 63
“The development of the nervous system may be affected by the action of both internal and external environmental factors [33]; therefore, it is conceivable that an aberrant microbial composition (intestinal dysbiosis) can influence neurological integrity and be involved in the expression of various neuropsychiatric dis…”
BackgroundResultAlteration of Gut Microbiota in Autism Spectrum Disorder: An Overview
Oh, D., & Cheon, K.-A. A. (2020) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.190039 · Cited by 60
The Influence of Food Intake Specificity in Children with Autism on Gut Microbiota
Tomova, A., Soltys, K., Kemenyova, P., Karhanek, M., & Babinska, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082797 · Cited by 53
“The different pathways involve the leakage of bacterial metabolites into the blood, and these, through cascades of reactions, alter the tight junctions in the blood–brain barrier, cortex, hippocampus, amygdala and cerebellum [18].”
BackgroundThe Molecular Gut-Brain Axis in Early Brain Development
Muhammad, F., Fan, B., Wang, R., Ren, J., Jia, S., Wang, L., Chen, Z., & Liu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315389 · Cited by 58
“Although the cause-effect relationship between ASD and gut microbiota is not elucidated, the diagnostic and therapeutic value of gut microbial metabolites as potential targets warrants research [130].”
BackgroundRelationships between Brain Activity, Tryptophan-Related Gut Metabolites, and Autism Symptomatology
Aziz-Zadeh, L., Ringold, S. M., Jayashankar, A., Kilroy, E., Butera, C., Jacobs, J. P., Tanartkit, S., Mahurkar-Joshi, S., Bhatt, R. R., Dapretto, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58459-1 · Cited by 51
“Pre-and postnatal microbial and neural disruptions may have profound effects on the development of the enteric and central nervous system 9 .”
Ertürk-Hasdemir, D., Ochoa‐Repáraz, J., Kasper, D. L., & Kasper, L. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662807 · Cited by 59
Zhang, L., Xu, Y., Li, H., Li, B., Duan, G., & Zhu, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263109 · Cited by 59
Shi, Z., Wang, S., Chen, M., Hu, A., Long, Q., & Lee, Y. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1336421 · Cited by 57
Pistollato, F., Forbes-Hernández, T. Y., Iglesias, R. C., Ruíz, R., Elexpuru-Zabaleta, M., Cianciosi, D., Giampieri, F., & Battino, M. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104579 · Cited by 52
Sen, P., Sherwin, E., Sandhu, K., Bastiaanssen, T. F. S., Moloney, G. M., Golubeva, A. V., Fitzgerald, P., Silva, A. P. V., Chruścicka‐Smaga, B., Olavarría‐Ramírez, L., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.08.007 · Cited by 60
“microbiota-gut-brain axis communication are thought to underlie symptoms of ASD in individuals (Kraneveld et al., 2016; Li and Zhou, 2016; Srikantha and Mohajeri, 2019).”
BackgroundMłynarska, E., Wasiak, J., Gajewska, A., Steć, G., Jasińska, J., Rysz, J., & Franczyk, B. (2024) · Nutrients · doi:10.3390/nu16121938 · Cited by 55
Gut Microbiota Ecology and Inferred Functions in Children With ASD Compared to Neurotypical Subjects
Vernocchi, P., Ristori, M. V., Guerrera, S., Guarrasi, V., Conte, F., Russo, A., Lupi, E., Albitar-Nehme, S., Gardini, S., Paci, P., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.871086 · Cited by 44
“Particularly, concentrations of propionic acid produced by Bacteroides may play beneficial effects for the enterocytes despite of high concentrations may be related to toxic effects (Frye et al., 2016; Srikantha and Mohajeri, 2019).”
BackgroundWasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47
The role of gut microbiota in depression: an analysis of the gut-brain axis
Irum, N., Afzal, T., Faraz, M. H., Aslam, Z., & Rasheed, F. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1185522 · Cited by 52
Gut instincts: vitamin D/vitamin D receptor and microbiome in neurodevelopment disorders
Ogbu, D., Xia, E., & Sun, J. (2020) · Open Biology · doi:10.1098/rsob.200063 · Cited by 52
“[3] predicted intestinal permeability caused by a reduction of barrierforming tight junctions could be a potential biomarker in ASD pathology.”
BackgroundInfluentialȘchiopu, C. G., Ștefănescu, G., Diaconescu, S., Bălan, G. G., Gimiga, N., Rusu, E. E., Moldovan, C., Popa, B. V., Tătăranu, E., OLTEANU, A. V., et al. (2022) · Nutrients · doi:10.3390/nu14081567 · Cited by 48
“Streptococcus 5-HT Inflammatory response, depressive/anxiety symptoms, cognitive impairment, Autistic Spectrum Disorder (ASD 6) Digestive symptoms relief, cognitive and affective improvement [38]”
BackgroundZebrafish Modeling of Autism Spectrum Disorders, Current Status and Future Prospective
Tayanloo-Beik, A., Hamidpour, S. K., Abedi, M., Shojaei, H., Rezaei–Tavirani, M., Namazi, N., Larijani, B. A., & Arjmand, B. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.911770 · Cited by 51
“and noradrenaline, which are also produced by certain species of bacteria, can affect the CNS through intestinal cells and development of various symptoms of ASD in patients (43).”
BackgroundCo-occurring conditions in children with Down syndrome and autism: a retrospective study
Spinazzi, N. A., Santoro, J. D., Pawlowski, K. G., Anzueto, G., Howe, Y. J., Patel, L., & Baumer, N. (2023) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-023-09478-w · Cited by 49
“For children with idiopathic ASD, multiple hypotheses have been proposed for the increased frequency of GI complaints, including disruption of the gut-brain axis and alteration in the microbiota [34].”
Borsom, E. M., Conn, K. A., Keefe, C. R., Herman, C., Orsini, G. M., Hirsch, A. H., Avila, M. P., Testo, G., Jaramillo, S. A., Bolyen, E. K., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03458-22 · Cited by 47
Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway?
Suprunowicz, M., Tomaszek, N., Urbaniak, A., Zackiewicz, K., Modzelewski, S., & Waszkiewicz, N. (2024) · Nutrients · doi:10.3390/nu16040549 · Cited by 44
“Maintaining an appropriate concentration of Lactobacillus spp. prevents the overgrowth of Candida ; however, autistic individuals exhibit reduced numbers of Lactobacillus spp. [56].”
BackgroundInfluentialDe Sales-Millán, A., Aguirre-Garrido, J. F., González-Cervantes, R. M., & Velázquez-Aragón, J. A. (2023) · doi:10.20944/preprints202305.1223.v1 · Cited by 44
“The communication between the microbiota, the gut and the brain involves the secretion of different metabolites, including short-chain fatty acids (SCFA), the structural components of bacteria and signalling molecules [99].”
BackgroundThe Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders
Młynarska, E., Barszcz, E., Budny, E., Gajewska, A., Kopeć, K., Wasiak, J., Rysz, J., & Franczyk, B. (2025) · Nutrients · doi:10.3390/nu17071135 · Cited by 44
“Increased BBB permeability has been associated with heightened microglial activity and a reduction in astrocyte numbers and functionality [52,76].”
InfluentialBidirectional Communication Between the Brain and Other Organs: The Role of Extracellular Vesicles
Zhou, W., Zhao, L., Mao, Z., Wang, Z., Zhang, Z., & Li, M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01345-5 · Cited by 46
“Disturbances in the gut microenvironment are associated with AD (Kesika et al. 2021; Megur et al. 2020), spectrum disorders (Socala et al. 2021; Srikantha & Mohajeri 2019), and PD (Mulak & Bonaz 2015; Sampson et al. 2016).”
BackgroundYang, C.-J., Xiao, H., Zhu, H., Du, Y., & Wang, L. (2024) · BioScience Trends · doi:10.5582/bst.2024.01123 · Cited by 47
Wang, X., Hu, R., Lin, F. H., Yang, T., Lu, Y., Sun, Z., Li, T., & Chen, J. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115212 · Cited by 50
Effects of Differences in Resistant Starch Content of Rice on Intestinal Microbial Composition
Wan, J., Wu, Y., Pham, Q., Li, R. W., Yu, L. L., Chen, M., Boué, S. M., YOKOYAMA, W. H., Li, B., & Wang, T. T. Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07887 · Cited by 45
The Crosstalk between Microbiome and Mitochondrial Homeostasis in Neurodegeneration
Borbolis, F., Mytilinaiou, E., & Palikaras, K. (2023) · Cells · doi:10.3390/cells12030429 · Cited by 46
Pérez-Fernández, C., Morales‐Navas, M., Aguilera-Sáez, L. M., Abreu, A. C., Guardia-Escote, L., Fernández, I., Garrido-Cárdenas, J. A., Colomina, M. T., Giménez, E., & Sánchez-Santed, F. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109341 · Cited by 44
Tao, K., Yuan, Y., Xie, Q., & Dong, Z. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115111 · Cited by 44
Indika, N.-L. R., Deutz, N. E. P., ENGELEN, M. P. K. J., Peiris, H., Wijetunge, S., & Perera, R. (2021) · Biochimie · doi:10.1016/j.biochi.2021.02.018 · Cited by 40
Marek, K., Cichoń, N., Saluk, J., Bijak, M., & Miller, E. D. (2022) · Nutrients · doi:10.3390/nu14132761 · Cited by 42
“It has been postulated that intestinal microflora dysfunction is related to CNS disease, including stroke [102].”
BackgroundMurakami, Y., Imamura, Y., Kasahara, Y., Yoshida, C., Momono, Y., Fang, K., Sakai, D., Konishi, Y., & Nishiyama, T. (2023) · Cells · doi:10.3390/cells12071087 · Cited by 39
“SCFAs can cross the blood–brain barrier (BBB) via monocarboxylate transporters located on endothelial cells and influence brain development by modulation of 5-HT and dopamine production [119,120].”
Osama, A., Anwar, A. M., Ezzeldin, S., Ahmed, E., Mahgoub, S., Ibrahim, O., Ibrahim, S., Abdelhamid, I. A., Bakry, U., Diab, A. A., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.036 · Cited by 42
Takyi, E., Nirmalkar, K., Adams, J. B., & Krajmalnik‐Brown, R. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2499580 · Cited by 45
Gut Microbiota and Disorders of the Central Nervous System
Vuotto, C., Battistini, L., Caltagirone, C., & Borsellino, G. (2020) · The Neuroscientist · doi:10.1177/1073858420918826 · Cited by 37
“In particular, an increasing number of studies have brought to light the influence that microbiota and its metabolites have beyond the GI tract, by altering immune and endocrine systems and by contributing to the onset and/or progression of neurodegenerative disorders, including Alzheimer’s disease (AD), Parkinson’s d…”
BackgroundInfluentialCuesta, C. M., Pascual, M., Pérez-Moraga, R., Rodríguez-Navarro, I., Garcia‐García, F., Ureña‐Peralta, J. R., & Guerri, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312830 · Cited by 40
Parolisi, S., Montanari, C., Borghi, E., Cazzorla, C., Zuvadelli, J., Tosi, M., Barone, R. M. E., Bensi, G., Bonfanti, C., Dionisi‐Vici, C., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106952 · Cited by 37
Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression
Li, B., Xu, M., Wang, Y., Feng, L., Xing, H., & Zhang, K. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116038 · Cited by 36
The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
Bhandari, R., Kaur, J., Kaur, S., & Kuhad, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1887141 · Cited by 37
“There is an increased movement of metabolites such as short-chain fatty acids (SCFA) which cause activation of immune response by binding to toll-like receptors 4 in the CNS [108].”
BackgroundInfluential
Metadata
- Authors
- Srikantha, P., & Mohajeri, M. H.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Mohajeri, M. Hasan
- ORCID
- Mohajeri, M. Hasan
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-04-29
- Volume
- 20
- Issue
- 9
- Pages
- 2115
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6539237
- OpenAlex
- W2943088522
- Cited by
- 400
- References
- 137
- Citations by year
- 2026: 32 · 2025: 68 · 2024: 60 · 2023: 64 · 2022: 67 · 2021: 56 · 2020: 42 · 2019: 11
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- autism spectrum disorder, gut microbiota, microbiota-gut-brain axis, dysbiosis, gastrointestinal symptoms, bacterial metabolites, short-chain fatty acids, indole, lipopolysaccharide, leaky gut, blood-brain barrier, mitochondrial dysfunction, oxidative stress, probiotics, phenylalanine metabolism, biomarkers
- MeSH terms
- Autism Spectrum Disorder, Gastrointestinal Microbiome, Animals, Brain, Child, Humans, Intestinal Mucosa, Intestines, Mitochondria, Risk Factors, Comorbidity, Probiotics, Biodiversity, Metabolic Networks and Pathways, Metabolomics, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.